News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
22,922 Results
Type
Article (1182)
Company Profile (1)
Press Release (21739)
Section
Business (3854)
Career Advice (97)
Deals (563)
Drug Delivery (1)
Drug Development (3053)
Employer Resources (4)
FDA (1144)
Job Trends (551)
News (8779)
Policy (751)
Tag
Academia (126)
Allergies (1)
Alliances (1485)
ALS (2)
Alzheimer's disease (99)
Antibody-drug conjugate (ADC) (8)
Approvals (1198)
Artificial intelligence (37)
Bankruptcy (5)
Best Places to Work (571)
Biosimilars (18)
Bladder cancer (16)
Brain cancer (1)
Breast cancer (31)
Cancer (200)
Cardiovascular disease (9)
Career advice (76)
Career pathing (1)
CAR-T (2)
Cell therapy (8)
Cervical cancer (5)
Clinical research (2876)
Collaboration (57)
Compensation (22)
Complete response letters (1)
COVID-19 (31)
CRISPR (1)
C-suite (14)
Cystic fibrosis (6)
Data (332)
Depression (1)
Diabetes (32)
Diagnostics (281)
Digital health (1)
Drug discovery (17)
Drug pricing (1)
Earnings (1388)
Editorial (1)
Employer branding (2)
Employer resources (4)
Events (2849)
Executive appointments (24)
FDA (1363)
Funding (39)
Gene editing (1)
Generative AI (3)
Gene therapy (43)
GLP-1 (14)
Government (87)
Guidances (7)
Healthcare (595)
HIV (1)
Huntington's disease (1)
Immunology and inflammation (4)
Indications (10)
Infectious disease (34)
Inflammatory bowel disease (3)
Influenza (1)
Intellectual property (4)
Interviews (15)
IPO (203)
Job creations (24)
Job search strategy (50)
JPM (1)
Kidney cancer (3)
Layoffs (3)
Legal (50)
Liver cancer (6)
Longevity (1)
Lung cancer (32)
Lymphoma (10)
Machine learning (3)
Management (2)
Manufacturing (17)
MASH (1)
Medical device (1088)
Medtech (1090)
Mergers & acquisitions (386)
Metabolic disorders (46)
Multiple sclerosis (9)
Neurodegenerative disease (15)
Neuropsychiatric disorders (3)
Neuroscience (134)
NextGen: Class of 2026 (188)
Non-profit (163)
Now hiring (3)
Obesity (9)
Opinion (5)
Ovarian cancer (4)
Pain (10)
Pancreatic cancer (6)
Parkinson's disease (9)
Partnered (2)
Patents (4)
Patient recruitment (20)
People (851)
Pharmacy benefit managers (1)
Phase 1 (644)
Phase 2 (1273)
Phase 3 (1174)
Pipeline (225)
Policy (1)
Postmarket research (135)
Preclinical (186)
Prostate cancer (11)
Radiopharmaceuticals (24)
Rare diseases (22)
Real estate (90)
Regulatory (835)
Reports (2)
Research institute (80)
Resumes & cover letters (34)
RSV (1)
Schizophrenia (2)
Series A (6)
Series B (7)
Startups (81)
Supply chain (2)
Vaccines (2)
Venture capital (1)
Weight loss (5)
Women's health (3)
Date
Last 7 days (25)
Last 30 days (89)
Last 365 days (1095)
2026 (113)
2025 (1120)
2024 (1314)
2023 (1546)
2022 (1930)
2021 (1974)
2020 (1744)
2019 (1645)
2018 (1212)
2017 (1301)
2016 (1260)
2015 (1359)
2014 (888)
2013 (701)
2012 (811)
2011 (852)
2010 (639)
Location
Africa (20)
Alabama (3)
Arizona (6)
Asia (1234)
Australia (216)
California (380)
Canada (81)
China (32)
Colorado (8)
Connecticut (8)
Delaware (25)
Europe (3074)
Florida (38)
Georgia (23)
Illinois (60)
India (5)
Indiana (14)
Iowa (1)
Japan (41)
Kansas (1)
Maine (1)
Maryland (12)
Massachusetts (351)
Michigan (39)
Minnesota (36)
Mississippi (1)
Missouri (3)
Nebraska (1)
New Hampshire (10)
New Jersey (147)
New Mexico (1)
New York (77)
North Carolina (87)
Northern California (195)
Ohio (14)
Oklahoma (1)
Oregon (3)
Pennsylvania (55)
Rhode Island (6)
South America (31)
South Carolina (2)
Southern California (110)
Tennessee (15)
Texas (53)
United States (1482)
Utah (10)
Virginia (12)
Washington D.C. (2)
Washington State (25)
Wisconsin (1)
22,922 Results for "visualant".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
ZEISS announces NMPA approval in China for powerful ophthalmic microscopes enhancing surgical visualization
February 3, 2026
·
5 min read
ChemPartner Unveils Updated Visual Identity and Digital Experience Reflecting Its Reputation as a Trusted Biopharma Partner
January 2, 2026
·
2 min read
Press Releases
VizMark Secures FDA 510k Clearance for VM1 Visual Tumor Marker, Advancing Precision in Breast Cancer Imaging
January 15, 2026
·
1 min read
Press Releases
SimBioSys and Ricoh 3D for Healthcare to Spotlight AI-Powered 3D Visualization in Webinar Featuring Clinical Use of TumorSight™ Viz
December 3, 2025
·
5 min read
Press Releases
Lucina Biotherapeutics Announces Publication in Science Translational Medicine Showing Restoration of Visual Function in Experimental Dry AMD
Breakthrough study demonstrates replenishment of essential VLC-PUFAs through a single intravitreal injection rejuvenates retinal structure and function in a naturally aged animal model.
September 24, 2025
·
1 min read
Press Releases
Vergent Bioscience Presents Phase 2B VISUALIZE Results Demonstrating Abenacianine for Injection (VGT-309) with Intraoperative Molecular Imaging Improved Tumor Visualization During Lung Surgery
May 23, 2025
·
5 min read
Press Releases
GenSight Biologics Announces Publication on Predictors of Final Visual Outcome in Patients Treated with LUMEVOQ® Gene Therapy
July 18, 2025
·
8 min read
Press Releases
OpRegen® (RG6501) 36-Month Visual Acuity Results Featured at Clinical Trials at the Summit 2025
June 23, 2025
·
11 min read
Press Releases
LUMA Vision Receives FDA Clearance for VERAFEYE 2D/4D Cardiac Visualization Platform
April 16, 2025
·
3 min read
Press Releases
Opus Genetics Doses First Patient in Pivotal LYNX-3 Phase 3 Trial Evaluating Phentolamine Ophthalmic Solution 0.75% in Keratorefractive Patients With Visual Disturbances Under Mesopic, Low-Contrast Conditions
September 5, 2025
·
6 min read
1 of 2,293
Next
